Researchers from the University of Oxford, funded by the National Institute for Health (NIHR) Research Oxford Biomedical Research Center (BRC) and the Oxford Health BRC, tested the responses of a representative group of 18,885 UK adults to a variety of COVID-19 vaccine messaging. The results are published today in the journal The Lancet Public Health.